MedTrace Logo

Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency

NCT02147782 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-09-23

No results posted yet for this study

Summary

Patients with chronic renal insufficiency usually develop secondary osteoporosis or bone loss, which is called renal osteodystrophy. Most of the previous studies focused on bone metabolism of patients in late stage of chronic renal insufficiency, especially those with chronic dialysis. In this study, bone metabolism of patients in different stages of chronic renal insufficiency will be observed to reveal the mechanism of development of renal osteodystrophy and provide clues for early intervention on renal osteodystrophy.

Conditions

  • Chronic Renal Insufficiency
  • Renal Osteodystrophy

Sponsors & Collaborators

  • Anhui Provincial Hospital

    collaborator OTHER_GOV

  • Huadong Hospital

    collaborator OTHER

  • Longhua Hospital

    collaborator OTHER

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Yongjun Wang, Doctor · Shanhgai University of TCM

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02147782 on ClinicalTrials.gov